In addition, studies on the molecular subtypes of bladder cancer revealed that FGFR3 mutations may be associated with the luminal-papillary subtype, which itself is associated with a less aggressive phenotype and significantly longer overall survival compared with other subtypes [9,32]. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.